Chronic kidney disease (CKD) affects nearly 800 million people worldwide and is among the top 10 causes of death, often remaining asymptomatic in early stages. Key risk factors include high blood pressure, high blood glucose, and high BMI. Early detection through regular testing and managing risk factors can slow progression and prevent severe complications.
Researchers discovered that a constipation drug, lubiprostone, can slow kidney function decline in CKD patients by improving gut microbiota and mitochondrial health, showing promise as a new treatment approach.
A study links chronic kidney disease, especially in dialysis patients, to a higher risk of Restless Legs Syndrome (RLS), which is associated with iron deficiency in the brain. RLS causes uncontrollable leg urges, worsens at night, and impacts sleep and mental health. Managing RLS involves addressing underlying conditions like iron deficiency, lifestyle changes, and symptom relief methods, although there is no cure.